切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (01) : 38 -42. doi: 10.3877/cma.j.issn.1674-6902.2019.01.007

所属专题: 文献

论著

lncRNA PACER促进脓毒症急性肺损伤炎症反应的实验研究
史柳嫣1, 辛伟2, 位全芳3, 甘志新4, 王丹4, 胡明冬4,()   
  1. 1. 721006 宝鸡,西安医学院附属宝鸡医院科教科
    2. 721001 宝鸡,陕西省宝鸡市中医院胸外科
    3. 400038 重庆,陆军军医大学(第三军医大学)生物医学分析测试中心
    4. 400037 重庆,陆军军医大学(第三军医大学)新桥医院呼吸与危重症医学科
  • 收稿日期:2018-12-07 出版日期:2019-02-20
  • 通信作者: 胡明冬
  • 基金资助:
    国家自然科学基金资助项目(81873421); 军事医学创新工程专项(18CXZ002); 重庆市自然科学基金(cstc2017jcyjAX0335)

Experimental study of lncRNA PACER promoting inflammatory response of acute lung injury induced by sepsis

Liuyan Shi1, Wei Xin2, Quanfang Wei3, Zhixin Gan4, Dan Wang4, Mingdong Hu4,()   

  1. 1. Department of Scientific Research and Education, The Affiliated Baoji Hospital, Xi′an Medical University, Baoji 721006, China
    2. Department of Thoracic Surgery, Baoji Traditional Chinese Medicine Hospital, Baoji 721001, China
    3. Biomedical Analysis Center, Army Medical University, Chongqing 400038, China
    4. Department of Respiratory and Critical Care Medicine, XinQiao Hospital, Army Medical University, Chongqing 400037, China
  • Received:2018-12-07 Published:2019-02-20
  • Corresponding author: Mingdong Hu
  • About author:
    Corresponding author: Hu Mingdong, Email:
引用本文:

史柳嫣, 辛伟, 位全芳, 甘志新, 王丹, 胡明冬. lncRNA PACER促进脓毒症急性肺损伤炎症反应的实验研究[J]. 中华肺部疾病杂志(电子版), 2019, 12(01): 38-42.

Liuyan Shi, Wei Xin, Quanfang Wei, Zhixin Gan, Dan Wang, Mingdong Hu. Experimental study of lncRNA PACER promoting inflammatory response of acute lung injury induced by sepsis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(01): 38-42.

目的

探讨lncRNA PACER对小鼠脓毒症急性肺损伤炎症反应的促进作用。

方法

分离和培养急性肺损伤和健康非吸烟者的肺泡巨噬细胞,以及获取细菌脂多糖(LPS)诱导的急性肺损伤(ALI)小鼠肺组织,采用qRT-PCR方法检测lncRNA PACER的表达;过表达或敲低PACER后,ELISA方法检测THP-1和RAW264.7细胞炎性因子肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)的表达;对LPS所致ALI小鼠,尾静脉注射PACER siRNA慢病毒后,ELISA检测小鼠血清炎性因子TNF-α、IL-6的表达,HE染色观察肺组织病理学变化。

结果

ALI患者肺泡巨噬细胞和ALI小鼠肺组织中lncRNA PACER表达均显著升高(P<0.01);细胞过表达PACER后,细胞炎性因子肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)的表达升高,而敲低PACER后,炎性因子TNF-α、IL-6的表达则降低(P<0.01);ALI小鼠敲低PACER后,小鼠肺组织和血清中炎性因子TNF-α、IL-6的表达均显著降低(P<0.01),肺组织损伤程度明显减弱。

结论

lncRNA PACER可显著促进脓毒症急性肺损伤炎症反应,为明确lncRNA PACER作为ALI防治的靶标提供了依据。

Objective

To investigate the effect of lncRNA PACER on inflammatory response of acute lung injury induced by sepsis in mice.

Methods

Human alveolar macrophages were collected from 20 cases of acute lung injury and health nonsmokers, and Lung tissues of ALI mice induced by LPS were obtained to detect the expression of lncRNA PACER by qRT-PCR. Then, lncRNA PACER was overexpressed or knocked down in THP-1 and RAW264.7 cells, the expressions of cytoinflammatory cytokines TNF-α and IL-6 were detected by ELISA. Furthermore, the ALI mice induced by LPS were injected PACER siRNA lentivirus into the tail vein, and the expressions of serum inflammatory factors TNF-α and IL-6 were detected by ELISA, meanwhile, the pathologic injury of lung tissue were observed by HE staining.

Results

The expression of lncRNA PACER was significantly increased in both alveolar macrophages of ALI patients and in lung tissues of ALI mice (P<0.01). After overexpression of PACER, the expression of inflammatory cytokines TNF-α and IL-6 were increased, while the expression of inflammatory cytokines TNF-α and IL-6 decreased after knocked down PACER (P<0.01). The expression of inflammatory cytokines TNF-α and IL-6 in lung tissue and serum of ALI mice were significantly decreased after the mice were knocked down PACER (P<0.01), and the pathological damage in lung tissues was significantly alleviated in PACER knockdown mice.

Conclusions

LncRNA PACER significantly promotes the inflammatory response of acute lung injury in sepsis, which provides basis for the identification of lncRNA PACER as a target for the prevention and treatment of ALI.

图1 lncRNA PACER在ALI患者(A)和小鼠(B)模型中的表达;与Control组比较,**P<0.01
图2 lncRNA PACER促进细胞炎症因子的表达结果;注:与NC,Control组比较,**P<0.01
图3 敲低lncRNA PACER减弱ALI小鼠炎症反应(HE×100);注:与Control组比较,**P<0.01
1
Sawa T. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response[J]. J Intensive Care, 2014, 2(1): 10.
2
Khorkova O,Hsiao J,Wahlestedt C. Basic biology and therapeutic implications of lncRNA[J]. Adv Drug Deliv Rev, 2015, 87: 15-24.
3
Marques-Rocha JL,Samblas M,Milagro FI, et al. Noncoding RNAs,cytokines, and inflammation-related diseases[J]. FASEB J, 2015, 29(9): 3595-3611.
4
Qu J,Li M,Zhong W, et al. Competing endogenous RNA in cancer:a new pattern of gene expression regulation[J]. Int J Clin Exp Med, 2015, 8(10): 17110-17116.
5
Su M,Xiao Y,Tang J, et al. Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer[J]. J Cancer, 2018, 9(22): 4156-4165.
6
Kim YK,Song J. The Role of Long Noncoding RNAs in Diabetic Alzheimer′s Disease.[J] J Clin Med, 2018, 7(11).
7
Li Z,Luo J. Epigenetic regulation of HOTAIR in advanced chronic myeloid leukemia[J]. Cancer Manag Res, 2018, 10: 5349-5362.
8
Krawczyk M,Emerson BM. p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes[J]. Elife, 2014, 3: e01776.
9
Charalambous MP,Lightfoot T,Speirs V, et al. Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue[J]. Br J Cancer, 2009, 101(1): 106-115.
10
Qian M,Yang X,Li Z, et al. P50-associated COX-2 extragenic RNA (PACER) overexpression promotes proliferation and metastasis of osteosarcoma cells by activating COX-2 gene[J]. Tumour Biol, 2016, 37(3): 3879-386.
11
Matsui M,Adib-Conquy M,Coste A, et al. Aqueous extract of Vitex trifolia L. (Labiatae) inhibits LPS-dependent regulation of inflammatory mediators in RAW 264.7 macrophages through inhibition of Nuclear Factor kappa B translocation and expression[J]. J Ethnopharmacol, 2012, 143(1): 24-32.
12
马李杰,李王平,金发光. 急性肺损伤/急性呼吸窘迫综合征发病机制的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(1): 65-68.
13
Sanchez Calle A,Kawamura Y,Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer i[J].Cancer Sci, 2018, 109(7): 2093-2100.
14
Sun X,Haider Ali MSS,Moran M. The role of interactions of long non-coding RNAs and heterogeneous nuclear ribonucleoproteins in regulating cellular functions[J]. Biochem J, 2017, 474(17): 2925-2935.
15
Wu H,Yang L,Chen LL. The Diversity of Long Noncoding RNAs and Their Generation[J]. Trends Genet, 2017, 33(8): 540-552.
16
Kwok ZH,Tay Y. Long noncoding RNAs: lincs between human health and disease[J]. Biochem Soc Trans, 2017, 45(3): 805-812.
17
Xue M,Zhuo Y,Shan B. MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease[J]. Methods Mol Biol, 2017, 1617: 1-25.
18
Schmitz SU,Grote P,Herrmann BG. Mechanisms of long noncoding RNA function in development and disease[J]. Cell Mol Life Sci, 2016, 73(13): 2491-509.
19
Li H,Shi H,Gao M, et al. Long non-coding RNA CASC2 improved acute lung injury by regulating miR-144-3p/AQP1 axis to reduce lung epithelial cell apoptosis[J]. Cell Biosci, 2018, 8: 15.
20
Li HB,Zi PP,Shi HJ, et al. [Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome[J]. Zhonghua Yi Xue Za Zhi, 2018, 98(41): 3354-3359.
21
Fan JC,Zeng F,Le YG, et al. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p[J]. J Cell Biochem, 2018, 119(8): 6391-6397.
22
Jin Y,Liu W,Liu X, et al. Transplantation of endothelial progenitor cells attenuated paraquat-induced acute lung injury via miR-141-3p-Notch-Nrf2 axis[J]. Cell Biosci, 2018, 8: 21.
23
Dai L,Zhang G,Cheng Z, et al. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury[J]. Connect Tissue Res, 2018, 59(6): 581-592.
24
Li H,Shi H,Ma N, et al. BML-111 alleviates acute lung injury through regulating the expression of lncRNA MALAT1[J]. Arch Biochem Biophys, 2018, 649: 15-21.
25
Dovizio M,Alberti S,Sacco A, et al. Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk[J]. Biochem Soc Trans, 2015, 43(4): 707-714.
26
Nasry WHS,Rodriguez-Lecompte JC,Martin CK. Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma[J]. Cancers (Basel), 2018, 10(10).
27
Tao SC,Guo SC,Zhang CQ. Platelet-derived Extracellular Vesicles:An Emerging Therapeutic Approach[J]. Int J Biol Sci, 2017, 13(7): 828-834.
28
Schiavone S,Contursi A,Grande R, et al. Therapeutic targeting of dysregulated cellular communication[J]. Ann Transl Med, 2017, 5(10): 222.
29
Chien PT,Lin CC,Hsiao LD, et al. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction[J]. Mol Cell Endocrinol, 2015, 409: 59-72.
30
Yang CC,Hsiao LD,Yang CM, et al. Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1[J]. Mol Neurobiol, 2017, 54(5): 3476-3491.
[1] 高文伯, 李明, 张运昊. 进展期肺癌炎症指数对三阴性乳腺癌的预后价值和临床意义[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 210-217.
[2] 韩媛媛, 热孜亚·萨贝提, 冒智捷, 穆福娜依·艾尔肯, 陆晨, 桑晓红, 阿尔曼·木拉提, 张丽. 组合式血液净化治疗对脓毒症患者血清炎症因子水平和临床预后的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 272-278.
[3] 孟建标, 张庚, 焦燕娜. 脓毒症合并心功能障碍患者早期肠道微生态改变的探讨[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 279-285.
[4] 陈宇, 冯芳, 张露, 刘健. 基于生物信息学分析筛选脓毒症心肌病关键致病基因[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 286-291.
[5] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[6] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[7] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[8] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[9] 钱晓英, 吴新, 徐婷婷. 颅脑损伤并发呼吸衰竭患者早期机械通气的效果分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 526-528.
[10] 熊欢庆, 李玉娟, 陈键, 刘刚, 李志超, 金发光. 丹参酮IIA及苦参碱组方对脂多糖致小鼠急性肺损伤的协同保护作用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 455-459.
[11] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[12] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[13] 李世明, 黄蔚, 刘玲. HMGB1介导脓毒症相关凝血功能障碍的作用机制及其治疗进展[J]. 中华重症医学电子杂志, 2023, 09(03): 269-273.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 蔡荇, 郑瑞强. 肝素结合蛋白在脓毒症中的应用及研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 487-490.
阅读次数
全文


摘要